Scientists Are Developing A Gene Therapy That Could Delay Aging

Everyone has pain or discomfort in their gut occasionally. Maybe you ate something that didn’t agree with you. Or you had an infection that made you sick to your stomach for a few days.

But if pain and other gut symptoms go on for weeks or longer, something more serious might be wrong. Digestive system diseases and disorders are very common. Around 60 to 70 million people in the U.S. live with a digestive disease.

A recent study suggests that methamphetamine overdose deaths are increasing sharply across America, finding the biggest increase among American Indians and Alaska Natives. 

Methamphetamine overdose deaths surged in an eight-year period in the United States, according to a study that will be published in JAMA Psychiatry. The analysis revealed rapid rises across all racial and ethnic groups, but American Indians and Alaska Natives had the highest death rates overall. The research was conducted at the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health.

Researchers at The Wistar Institute have discovered a new enzymatic function of the Epstein-Barr Virus (EBV) protein EBNA1, a critical factor in EBV’s ability to transform human cells and cause cancer. Published in Cell, this study provides new indications for inhibiting EBNA1 function, opening up fresh avenues for the development of therapies to treat EBV-associated cancers.

Oisín Biotechnologies' ground-breaking research and technology is demonstrating that the solution to mitigating the effects of age-related diseases is to address the damage created by the aging process itself. The late preclinical stage biotechnology company was recently named one of the 10 breakthrough technologies of 2020 in MIT Technology Review. Additionally, the company has also closed a $3 million pres-seed SAFE funding round to further R&D efforts.